CD8A and neoplasm: Next, consistent with the previous finding, Bor treatment resulted in a significant increase in the proportion of tumor-recruited CD4+ and CD8+ T cells expressing IFN-γ, a main cytokine marker for the activity of tumor-infiltrating lymphocytes [70], while it had no significant effects on the amount of IFN-γ+ T cells in the spleen.